Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With EGFR and MET-Driven Lung Cancer: Case Report

We previously published in the Journal of Thoracic Oncology the case of a patient with EGFR and MET-driven lung cancer and extracranial response to capmatinib and osimertinib. Here, we report on a second patient treated with the same combination, revealing complete and durable intracranial response....

Descripción completa

Detalles Bibliográficos
Autores principales: Gautschi, Oliver, Diebold, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474278/
https://www.ncbi.nlm.nih.gov/pubmed/34590012
http://dx.doi.org/10.1016/j.jtocrr.2021.100162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474278/
https://www.ncbi.nlm.nih.gov/pubmed/34590012
http://dx.doi.org/10.1016/j.jtocrr.2021.100162

Ejemplares similares